IHS Chemical Week

Regions :: North America

Lonza Acquires U.S. Contract Manufacturer

11:40 PM MDT | August 31, 2010 | Deepti Ramesh

Lonza says it has entered the viral-based manufacturing market with its acquisition of Vivante GMP Solutions (Houston, TX). Vivante is a custom manufacturing organization producing viral-based therapeutics, and the acquisition advances Lonza’s strategy to broaden its biologics custom service offering for the growing viral vaccine and gene therapy markets, Lonza says. Financial terms of the acquisition were not disclosed. “Lonza is strategically committed to being successful in the growing viral marketplace,” says David Smith, head of Therapeutic...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa